Contezolid

Contezolid is an antibiotic of the oxazolidinone class. It is effective against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactiae, and other bacteria.
In 2021, it was approved by the National Medical Products Administration of China for the treatment of complicated skin and soft tissue infections.
A prodrug of contezolid, contezolid acefosamil, which is formulated for IV administration is in Phase III clinical trials for diabetic foot infection.